Abstract
Wilms tumor (4 %) and neuroblastoma (8 %) make up the largest group of extracranial solid tumors of childhood. Most of these patients present before 5 years of age. Mesoblastic nephroma and stage IVS neuroblastoma are seen in children less than 1 year of age. Several other primary renal tumors may be seen in children. Adrenocortical carcinoma and pheochromocytoma are rare. The imaging features of these tumors will be shown. Rhabdomyosarcoma of the bladder will also be discussed.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Li J. Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics. 2008;121:e1470.
Lowe LH, Isuani BH, Heller RM, et al. Pediatric renal masses: Wilms tumor and beyond. Radiographics. 2000;20:1585–603.
National Cancer Institute. Wilms tumor and other childhood kidney tumors treatment (PDQ). Available at http://www.cancer.gov/cancertopics/pdq/treatment/wilms/Patient/page1. Accessed 24 Jan 2012.
Miniati D, Gay AN, Parks KV, et al. Imaging accuracy and incidence of Wilms’ and non-Wilms’ renal tumors in children. J Pediatr Surg. 2008;43:1301–7.
Mullen EA, Weldon C, Kreidberg JA. Pediatric renal tumors. In: Ellis Avner WH, Niaudet P, Norishige Y, editors. Pediatric nephrology. 6th ed. Berlin/Heidelberg: Springer; 2009. p. 1431–55.
Chaudry G, Perez-Atayde AR, Ngan BY, et al. Imaging of congenital mesoblastic nephroma with pathological correlation. Pediatr Radiol. 2009;39:1080–6.
Rohrschneider WK, Weirich A, Rieden K, et al. US, CT and MR imaging characteristics of nephroblastomatosis. Pediatr Radiol. 1998;28:435–43.
Owens CM, Brisse HJ, Olsen OE, et al. Bilateral disease and new trends in Wilms tumour. Pediatr Radiol. 2008;38:30–9.
Sethi AT, Narla LD, Fitch SJ, et al. Best cases from the AFIP: Wilms tumor in the setting of bilateral nephroblastomatosis. Radiographics. 2010;30:1421–5.
Ritchey M, Daley S, Shamberger RC, et al. Ureteral extension in Wilms’ tumor: a report from the National Wilms’ Tumor Study Group (NWTSG). J Pediatr Surg. 2008;43:1625–9.
Rutigliano DN, Kayton ML, Steinherz P, et al. The use of preoperative chemotherapy in Wilms’ tumor with contained retroperitoneal rupture. J Pediatr Surg. 2007;42:1595–9.
Siegel MJ, Chung EM. Wilms’ tumor and other pediatric renal masses. Magn Reson Imaging Clin N Am. 2008;16:479–97. vi.
Smets AM, de Kraker J. Malignant tumours of the kidney: imaging strategy. Pediatr Radiol. 2010;40:1010–8.
Taguchi S, Shono T, Mori D, et al. Extrarenal Wilms tumor in children with unfavorable histology: a case report. J Pediatr Surg. 2010;45:e19–22.
Blitman NM, Berkenblit RG, Rozenblit AM, et al. Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol. 2005;185:268–72.
Hakimi AA, Koi PT, Milhoua PM, et al. Renal medullary carcinoma: the Bronx experience. Urology. 2007;70:878–82.
Armah HB, Parwani AV, Surti U, et al. Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature. Diagn Pathol. 2009;4:15.
Fleitz JM, Wootton-Gorges SL, Wyatt-Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol. 2003;33:540–5.
Abramson SJ, Price AP. Imaging of pediatric lymphomas. Radiol Clin North Am. 2008;46:313–38. ix.
Wong-You-Cheong JJ, Woodward PJ, Manning MA, et al. From the archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006;26:553–80.
National Cancer Institute. Childhood rhabdomyosarcoma treatment (PDQ). Available at http://wwwcancergov/cancertopics/pdq/treatment/childrhabdomyosarcoma/HealthProfessional/page5 2010. Accessed 25 Jan 2012.
Pappo A. Pediatric bone and soft tissue sarcomas. Berlin/New York: Springer; 2006.
Arndt C, Rodeberg D, Breitfeld PP, et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. J Urol. 2004;171:2396–403.
Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997;80:2321–32.
Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol. 1997;19:428–32.
Kushner BH, Kramer K, LaQuaglia MP, et al. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Med Pediatr Oncol. 2003;41:508–15.
DuBois SG, Kalika Y, Lukens JN, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol. 1999;21:181–9.
Abramson SJ BW, Ruzal-Shapiro C, et al. Cervical neuroblastoma in eleven infants: a tumor with favorable prognosis. Clinical and radiologic (US, CT, MRI) findings. Pediatr Radiol. 1993;23:253–7.
Abramson SJ BW, Stolar C. Stage lV N neuroblastoma: MRI diagnosis of left supraclavicular “Virchow’s” nodal spread. Pediatr Radiol. 1996;26:717–9.
Cowie F, Corbett R, Pinkerton CR. Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol. 1997;28:429–32.
Kammen BF, Matthay KK, Pacharn P, et al. Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol. 2001;176:755–9.
Matthay KK, Brisse H, Couanet D, et al. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Cancer. 2003;98:155–65.
D’Ambrosio N, Lyo JK, Young RJ, et al. Imaging of metastatic CNS neuroblastoma. AJR Am J Roentgenol. 2010;194:1223–9.
Kramer K, Kushner BH, Modak S, et al. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma. J Neurooncol. 2010;97:409–18.
Croog VJ, Kramer K, Cheung NK, et al. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2010;78:849–54.
Aronson M, Smoker WR, Oetting GM. Hemorrhagic intracranial parenchymal metastases from primary retroperitoneal neuroblastoma. Pediatr Radiol. 1995;25:284–5.
Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.
Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349–63.
Brodeur GM, Fong CT. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 1989;41:153–74.
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203–16.
Kaneko Y, Knudson AG. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer. 2000;29:89–95.
Kushner B. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45:1172–88.
Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children’s Cancer Group study. J Clin Oncol. 2000;18:1260–8.
Castleberry RP, Pritchard J, Ambros P, et al. The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer. 1997;33:2113–6.
Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298–303.
Abramson SJ. Adrenal neoplasms in children. Radiol Clin North Am. 1997;35:1415–53.
Tiedeman K, Pritchard J, Long R, et al. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Eur J Pediatr. 1981;137:217–9.
Altman A, Baehner RL. Favorable prognosis for survival in children with coincident opsomyoclonus and neuroblastoma. Cancer. 1976;37:846–52.
Baker ME, Kirks DR, Korobkin M, et al. The association of neuroblastoma and myoclonic encephalopathy: an imaging approach. Pediatr Radiol. 1984;15:185.
Toma P, Lucigrai G, Marzoli A, et al. Prenatal diagnosis of metastatic adrenal neuroblastoma with sonography and MR imaging. AJR Am J Roentgenol. 1994;162:1183–4.
Sauvat F, Sarnacki S, Brisse H, et al. Outcome of suprarenal localized masses diagnosed durint the preinatal period: a retrospective multicenter study. Cancer. 2002;94:2474–80.
Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 1998;16:1265–9.
Woods WG, Gao RN, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041–6.
Nishihira H, Toyoda Y, Tanaka Y, et al. Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol. 2000;18:3012–7.
Hendry GMA. Cystic neuroblastoma of the adrenal gland—a potential source of error in ultrasound diagnosis. Pediatr Radiol. 1982;12:204–6.
Atkinson GS ZG, Lorenzo RI. Cystic neuroblastoma in infants: radiographic and pathologic features. AJR Am J Roentgenol. 1986;146:113–7.
Burbige K. Prenatal adrenal hemorrhage confirmed by postnatal surgery. J Urol. 1993;150:1866–9.
Strouse P. Antenatal sonographic findings of fetal adrenal hemorrhage. J Clin Ultrasound. 1995;23:442–6.
Forman HP, Leonidas JC, Berdon WE, et al. Congenital neuroblastoma: evaluation with multimodality imaging. Radiology. 1990;175:365–9.
Ho PTC, Estroff JA, Kozakewich H, et al. Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children’s Hospital. Pediatrics. 1993;92:358–64.
Fenart D, Deville A, Donzeau M, et al. Neuroblastoma retroperitoneal diagnostique in utero. J Radiol. 1983;64:359–61.
Acharya S, Jayabose S, Kogan S, et al. Prenatally diagnosed neuroblastoma. Cancer. 1997;80:304–10.
Guglielmi M, De Bernardi B, Rizzo A, et al. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol. 1996;14:1537–44.
Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Group study. J Clin Oncol. 2000;18:477–86.
Siegel MJG, Ishwaran H, Fletcher BD, et al. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology. 2002;223:168–75.
Pfluger T, Schmied C, Porn U, et al. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma. AJR Am J Roentgenol. 2003;181:1115–24.
Kornreich L, Horev G, Kaplinsky C, et al. Neuroblastoma: evaluation with contrast enhanced MR imaging. Pediatr Radiol. 1991;21:566–9.
Shulkin BL, Shapiro B, Hutchinson RJ. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med. 1992;33:1735–40.
Siegel MJ, Jamroz GA, Glazer HS, Abramson CL. MR imaging of intraspinal extension of neuroblastoma. J Comput Assist Tomogr. 1986;10:593–5.
Tanabe M, Yoshida H, Ohnuma N, et al. Imaging of neuroblastoma in patients identified by mass screening using urinary catecholamine metabolites. J Pediatr Surg. 1993;28:617–21.
Couanet DGA, Hartmann O, et al. Bone marrow metastases in children’s neuroblastoma studied by magnetic resonance imaging. Prog Clin Biol Res. 1988;27:547–55.
Dietrich RKH, Lenarsky C, et al. Neuroblastoma: the role of MR imaging. AJR Am J Roentgenol. 1987;148:937–42.
Ruzal-Shapiro CBW, Cohen M, Abramson S. MR imaging of diffuse bone marrow replacement in pediatric patients with cancer. Radiology. 1991;181:587–9.
Tanabe M, Ohnuma N, Iwai J, et al. Bone marrow metastasis of neuroblastoma analyzed by MRI and its influence on prognosis. Med Pediatr Oncol. 1995;24:292–9.
Tanabe M, Takahashi H, Ohnuma N, et al. Evaluation of bone marrow metastasis of neuroblastoma and changes after chemotherapy by MRI. Med Pediatr Oncol. 1993;21:54–9.
Lebtahi N, Gudinchet F, Nenadov-Beck M, et al. Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI. J Nucl Med. 1997;38:1389–92.
Brody AS, Frush DP, Huda W, et al. Radiation risk to children from computed tomography. Pediatrics. 2007;120:677–82.
Achatz MI, Hainaut P, Ashton-Prolla P. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? Lancet Oncol. 2009;10:920–5.
Podrasky AE, Stark DD, Hattner RS, et al. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP. AJR Am J Roentgenol. 1983;141:469–72.
Bouvier JF, Philip T, Chauvot P, et al. Pitfalls and solutions in neuroblastoma diagnosis using radiciodine MlBG: an experience with 50 cases. Prog Clin Biol Res. 1988;271:707–20.
Vik TA, Pfluger T, Kadota R, et al. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: results from a prospective multicenter trial. Pediatr Blood Cancer. 2009;52:784–90.
Brodeur GM. Molecular pathology of human neuroblastomas [review]. Semin Diagn Pathol. 1994;11:118–25.
Sharpe S, Shulkin BL, Gelfand MJ, et al. 123I-MIBG-scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med. 2009;50:1237–43.
Shulkin BL, Hutchinson RJ, Castle VP, et al. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology. 1996;199:743–50.
Taggart DR, Han MM, Quach A, et al. Comparison of iodine-123 metaiodobenzylguanidine (MlBG) scan and [8F] fluorodeoxyglucose positron emission tomography to evaluate response after iodine 131 MlBG therapy for relapsed neuroblastoma. J Clin Oncol. 2009;27:5343–9.
Kushner BH, Yeung H, Larson SW, et al. Extending positron emission tomography scan utility to high risk neuroblastoma: flourine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.
Hossein J. l-123 MIBG scintigraphy or FDG PET for the imaging of neuroblastoma. J Nucl Med. 2009;50:1237–43.
Manil L, Edeline V, Lumbroso J, et al. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med. 1996;37:893–6.
Liou LS, Kay R. Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am. 2000;27:403–21.
McHugh K. Renal and adrenal tumours in children. Cancer Imaging. 2007;7:41–51.
Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A. 2001;98:9330–5.
Tucci Jr S, Martins AC, Suaid HJ, et al. The impact of tumor stage on prognosis in children with adrenocortical carcinoma. J Urol. 2005;174:2338–42. discussion 2342.
Cohen M. Imaging of children with cancer. St. Louis: Mosby Yearbook, Elsevier 1992; p. 134–76.
Elsayes KM, Mukundan G, Narra VR, et al. Adrenal masses: MR imaging features with pathologic correlation. Radiographics. 2004;24 Suppl 1:S73–86.
Ciftci AO, Tanyel FC, Senocak ME, et al. Pheochromocytoma in children. J Pediatr Surg. 2001;36:447–52.
Acknowledgment
I would like to thank Yvette Mingo for her assistance in the manuscript preparation and Carolina Montalvo and Michael Sohn for their assistance in the image preparation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Abramson, S.J., Price, A.P., Sohn, M.J. (2013). Pediatric Genitourinary Tumor Imaging. In: Bach, A., Zhang, J. (eds) Atlas of Genitourinary Oncological Imaging. Atlas of Oncology Imaging, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4872-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4872-3_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4871-6
Online ISBN: 978-1-4614-4872-3
eBook Packages: MedicineMedicine (R0)